UBS Group’s Icosavax, Inc. Common Stock ICVX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-256,869
| Closed | -$4.05M | – | 8929 |
|
2023
Q4 | $4.05M | Buy |
256,869
+242,325
| +1,666% | +$3.82M | ﹤0.01% | 2193 |
|
2023
Q3 | $113K | Buy |
14,544
+7,183
| +98% | +$55.7K | ﹤0.01% | 4648 |
|
2023
Q2 | $73.1K | Buy |
7,361
+6,812
| +1,241% | +$67.6K | ﹤0.01% | 5184 |
|
2023
Q1 | $3.18K | Sell |
549
-2,549
| -82% | -$14.8K | ﹤0.01% | 7261 |
|
2022
Q4 | $24.6K | Sell |
3,098
-172,012
| -98% | -$1.37M | ﹤0.01% | 6260 |
|
2022
Q3 | $553K | Sell |
175,110
-15,378
| -8% | -$48.6K | ﹤0.01% | 3285 |
|
2022
Q2 | $1.09M | Buy |
+190,488
| New | +$1.09M | ﹤0.01% | 2825 |
|